Compare Smruthi Organic with Similar Stocks
Dashboard
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.64 times
Poor long term growth as Net Sales has grown by an annual rate of -4.22% and Operating profit at -22.92% over the last 5 years
Flat results in Mar 26
With ROE of 5.2, it has a Attractive valuation with a 1.9 Price to Book Value
Majority shareholders : Promoters
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
INR 138 Cr (Micro Cap)
37.00
36
0.00%
0.08
5.20%
1.95
Total Returns (Price + Dividend) 
Latest dividend: 1.5 per share ex-dividend date: Jun-13-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Smruthi Organics Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials
Smruthi Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 7 July 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, and financial stability, despite ongoing challenges in long-term growth and recent flat quarterly performance.
Read full news article
Smruthi Organics Ltd Downgraded to Sell Amid Flat Financials and Mixed Technical Signals
Smruthi Organics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 29 June 2026. This revision reflects a combination of deteriorating financial trends, subdued quality metrics, and a shift in technical indicators, despite some valuation attractiveness. The company’s Mojo Score now stands at 48.0, signalling caution for investors amid a challenging operating environment.
Read full news article
Smruthi Organics Ltd Upgraded to Hold as Technicals Improve Amid Flat Financials
Smruthi Organics Ltd has seen its investment rating upgraded from Sell to Hold as of 22 June 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, and financial stability despite ongoing challenges in long-term growth. The micro-cap pharmaceutical company’s Mojo Score rose to 58.0, signalling a cautious but positive shift in investor sentiment.
Read full news article Announcements 
Closure of Trading Window
29-Jun-2026 | Source : BSENotice of Closure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-May-2026 | Source : BSENewspaper Advertisement- Financial Results
Intimation Of Record Date For Payment Of Dividend
14-May-2026 | Source : BSEIntimation of Record Date
Corporate Actions 
No Upcoming Board Meetings
Smruthi Organics Ltd has declared 15% dividend, ex-date: 31 Jul 26
No Splits history available
Smruthi Organics Ltd has announced 2:1 bonus issue, ex-date: 16 Mar 21
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Eaga Purushotham Malaiah (41.23%)
Smitha Gupta (1.21%)
28.7%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 30.51% vs -29.46% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -23.57% vs -32.04% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -10.71% vs -12.16% in Sep 2024
Growth in half year ended Sep 2025 is 740.00% vs -103.44% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -17.10% vs -0.08% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 77.44% vs -35.75% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -19.08% vs -1.28% in Mar 2025
YoY Growth in year ended Mar 2026 is -3.65% vs -0.84% in Mar 2025






